The Influence of Hydrophobic Blocks of PEO-Containing Copolymers on Glyceryl Monooleate Lyotropic Liquid Crystalline Nanoparticles for Drug Delivery

Overview

Journal Polymers (Basel)

Publisher MDPI

Date 2021 Aug 28

PMID 34451146

Citations 2

Authors

Aleksander Forys

Maria Chountoulesi

Barbara Mendrek

Tomasz Konieczny

Theodore Sentoukas

Marcin Godzierz

Aleksandra Kordyka

Costas Demetzos

Stergios Pispas

Barbara Trzebicka

Affiliations

Soon will be listed here.

Abstract

The investigation of properties of amphiphilic block copolymers as stabilizers for non-lamellar lyotropic liquid crystalline nanoparticles represents a fundamental issue for the formation, stability and upgraded functionality of these nanosystems. The aim of this work is to use amphiphilic block copolymers, not studied before, as stabilizers of glyceryl monooleate 1-(cis-9-octadecenoyl)--glycerol (GMO) colloidal dispersions. Nanosystems were prepared with the use of poly(ethylene oxide)--poly(lactic acid) (PEO--PLA) and poly(ethylene oxide)--poly(5-methyl-5-ethyloxycarbonyl-1,3-dioxan-2-one) (PEO--PMEC) block copolymers. Different GMO:polymer molar ratios lead to formulation of nanoparticles with different size and internal organization, depending on the type of hydrophobic block. Resveratrol was loaded into the nanosystems as a model hydrophobic drug. The physicochemical and morphological characteristics of the prepared nanosystems were investigated by dynamic light scattering (DLS), cryogenic transmission electron microscopy (cryo-TEM), fast Fourier transform (FFT) analysis and X-ray diffraction (XRD). The studies allowed the description of the lyotropic liquid crystalline nanoparticles and evaluation of impact of copolymer composition on these nanosystems. The structures formed in GMO:block copolymer colloidal dispersions were compared with those discussed previously. The investigations broaden the toolbox of polymeric stabilizers for the development of this type of hybrid polymer/lipid nanostructures.

Citing Articles

Injectable In-Situ Forming Depot Based on PLGA and PLGA-PEG-PLGA for Sustained-Release of Risperidone: In Vitro Evaluation and Pharmacokinetics in Rabbits.

Rezaeian Shiadeh S, Hadizadeh F, Khodaverdi E, Gorji Valokola M, Rakhshani S, Kamali H Pharmaceutics. 2023; 15(4).

PMID: 37111714 PMC: 10143068. DOI: 10.3390/pharmaceutics15041229.

Serum Albumin Nanoparticles: Problems and Prospects.

Hornok V Polymers (Basel). 2021; 13(21).

PMID: 34771316 PMC: 8586933. DOI: 10.3390/polym13213759.

References

Tran N, Bye N, Moffat B, Wright D, Cuddihy A, Hinton T . Dual-modality NIRF-MRI cubosomes and hexosomes: High throughput formulation and in vivo biodistribution. Mater Sci Eng C Mater Biol Appl. 2016; 71:584-593. DOI: 10.1016/j.msec.2016.10.028. View

Abuchowski A, McCoy J, Palczuk N, van Es T, DAVIS F . Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. J Biol Chem. 1977; 252(11):3582-6. View

Chountoulesi M, Perinelli D, Forys A, Bonacucina G, Trzebicka B, Pispas S . Liquid crystalline nanoparticles for drug delivery: The role of gradient and block copolymers on the morphology, internal organisation and release profile. Eur J Pharm Biopharm. 2020; 158:21-34. DOI: 10.1016/j.ejpb.2020.08.008. View

Thomas A, Muller S, Frey H . Beyond poly(ethylene glycol): linear polyglycerol as a multifunctional polyether for biomedical and pharmaceutical applications. Biomacromolecules. 2014; 15(6):1935-54. DOI: 10.1021/bm5002608. View

Akhlaghi S, Ribeiro I, Boyd B, Loh W . Impact of preparation method and variables on the internal structure, morphology, and presence of liposomes in phytantriol-Pluronic(®) F127 cubosomes. Colloids Surf B Biointerfaces. 2016; 145:845-853. DOI: 10.1016/j.colsurfb.2016.05.091. View

Boyd B, Whittaker D, Khoo S, Davey G . Lyotropic liquid crystalline phases formed from glycerate surfactants as sustained release drug delivery systems. Int J Pharm. 2006; 309(1-2):218-26. DOI: 10.1016/j.ijpharm.2005.11.033. View

Gou M, Wei X, Men K, Wang B, Luo F, Zhao X . PCL/PEG copolymeric nanoparticles: potential nanoplatforms for anticancer agent delivery. Curr Drug Targets. 2011; 12(8):1131-50. DOI: 10.2174/138945011795906642. View

Akhlaghi S, Loh W . Interactions and release of two palmitoyl peptides from phytantriol cubosomes. Eur J Pharm Biopharm. 2017; 117:60-67. DOI: 10.1016/j.ejpb.2017.03.022. View

Nisini R, Poerio N, Mariotti S, De Santis F, Fraziano M . The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases. Front Immunol. 2018; 9:155. PMC: 5807682. DOI: 10.3389/fimmu.2018.00155. View

10.

Khan S, McCabe J, Hill K, Beales P . Biodegradable hybrid block copolymer - lipid vesicles as potential drug delivery systems. J Colloid Interface Sci. 2019; 562:418-428. DOI: 10.1016/j.jcis.2019.11.101. View

11.

Barriga H, Ces O, Law R, Seddon J, Brooks N . Engineering Swollen Cubosomes Using Cholesterol and Anionic Lipids. Langmuir. 2019; 35(50):16521-16527. DOI: 10.1021/acs.langmuir.9b02336. View

12.

Li Y, Angelova A, Hu F, Garamus V, Peng C, Li N . pH Responsiveness of Hexosomes and Cubosomes for Combined Delivery of Oil and Doxorubicin. Langmuir. 2019; 35(45):14532-14542. DOI: 10.1021/acs.langmuir.9b02257. View

13.

Tyler B, Gullotti D, Mangraviti A, Utsuki T, Brem H . Polylactic acid (PLA) controlled delivery carriers for biomedical applications. Adv Drug Deliv Rev. 2016; 107:163-175. DOI: 10.1016/j.addr.2016.06.018. View

14.

Pan X, Han K, Peng X, Yang Z, Qin L, Zhu C . Nanostructured cubosomes as advanced drug delivery system. Curr Pharm Des. 2013; 19(35):6290-7. DOI: 10.2174/1381612811319350006. View

15.

Elgindy N, Mehanna M, Mohyeldin S . Self-assembled nano-architecture liquid crystalline particles as a promising carrier for progesterone transdermal delivery. Int J Pharm. 2016; 501(1-2):167-79. DOI: 10.1016/j.ijpharm.2016.01.049. View

16.

Salehi B, Mishra A, Nigam M, Sener B, Kilic M, Sharifi-Rad M . Resveratrol: A Double-Edged Sword in Health Benefits. Biomedicines. 2018; 6(3). PMC: 6164842. DOI: 10.3390/biomedicines6030091. View

17.

Chen H, Fan Y, Zhang N, Trepout S, Ptissam B, Brulet A . Fluorescent polymer cubosomes and hexosomes with aggregation-induced emission. Chem Sci. 2021; 12(15):5495-5504. PMC: 8179552. DOI: 10.1039/d1sc00270h. View

18.

Wu H, Li J, Zhang Q, Yan X, Guo L, Gao X . A novel small Odorranalectin-bearing cubosomes: preparation, brain delivery and pharmacodynamic study on amyloid-β₂₅₋₃₅-treated rats following intranasal administration. Eur J Pharm Biopharm. 2011; 80(2):368-78. DOI: 10.1016/j.ejpb.2011.10.012. View

19.

Meli V, Caltagirone C, Falchi A, Hyde S, Lippolis V, Monduzzi M . Docetaxel-Loaded Fluorescent Liquid-Crystalline Nanoparticles for Cancer Theranostics. Langmuir. 2015; 31(35):9566-75. DOI: 10.1021/acs.langmuir.5b02101. View

20.

Kluzek M, Tyler A, Wang S, Chen R, Marques C, Thalmann F . Influence of a pH-sensitive polymer on the structure of monoolein cubosomes. Soft Matter. 2017; 13(41):7571-7577. DOI: 10.1039/c7sm01620d. View